Literature DB >> 34232352

Zinc finger and BTB domain-containing protein 20 aggravates angiotensin II-induced cardiac remodeling via the EGFR-AKT pathway.

Fangfang Li1,2, Miaomiao Du1,2, Yiming Yang1,2, Zhu Wang1,2, Hu Zhang1,2, Xiaoyu Wang1,2, Qing Li3,4.   

Abstract

Zinc finger and BTB domain-containing protein 20 (ZBTB20) play an important role in glucose and lipid homeostasis. ZBTB20 was shown to be a crucial protein for the maintenance of cardiac contractile function. However, the role of ZBTB20 in cardiac response remodeling has not been elucidated. Thus, this study aimed to explore the role of ZBTB20 in cardiac remodeling following angiotensin II insult. Mice were subjected to angiotensin II infusion to induce a cardiac adverse remodeling model. An adeno-associated virus (AAV) 9 system was used to deliver ZBTB20 to the mouse heart. Here, we demonstrate that ZBTB20 expression is elevated in angiotensin II-induced cardiac remodeling and in response to cardiomyocyte insults. Furthermore, AAV9-mediated overexpression of ZBTB20 caused cardiac wall hypertrophy, chamber dilation, increased fibrosis, and reduced ejection fraction. Additionally, ZBTB20 siRNA protected cardiomyocytes from angiotensin II-induced hypertrophy. Mechanistically, ZBTB20 interferes with EGFR and Akt signaling and modulates the remodeling response. Overexpression of constitutively active Akt counteracts ZBTB20 knockdown-mediated protection of adverse cardiac remodeling. These findings illustrate the role of ZBTB20 in the transition of adverse cardiac remodeling toward heart failure and provide evidence for the molecular programs inducing adverse cardiac remodeling. KEY MESSAGES: ZBTB20 is a transcription factor from the POK family. ZBTB20 is upregulated in heart tissue treated with angiotensin II. ZBTB20 influences cardiomyocyte hypertrophy via the EGFR-Akt pathway. Akt continuous activation leads to similar results to ZBTB20 overexpression.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adverse cardiac remodeling; Akt; Angiotensin II; EGFR; ZBTB20

Mesh:

Substances:

Year:  2021        PMID: 34232352     DOI: 10.1007/s00109-021-02103-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  28 in total

1.  EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.

Authors:  Dandan Liang; Peng Zhong; Jie Hu; Feng Lin; Yuanyuan Qian; Zheng Xu; Jingying Wang; Chunlai Zeng; Xiaokun Li; Guang Liang
Journal:  J Mol Cell Cardiol       Date:  2015-03-07       Impact factor: 5.000

2.  Zbtb20 Restrains CD8 T Cell Immunometabolism and Restricts Memory Differentiation and Antitumor Immunity.

Authors:  Yanbo Sun; Nicholas K Preiss; Kristine B Valenteros; Yasmin Kamal; Young-Kwang Usherwood; H Robert Frost; Edward J Usherwood
Journal:  J Immunol       Date:  2020-09-30       Impact factor: 5.422

3.  Zbtb20 Regulates Developmental Neurogenesis in the Olfactory Bulb and Gliogenesis After Adult Brain Injury.

Authors:  Thorsten R Doeppner; Josephine Herz; Mathias Bähr; Anton B Tonchev; Anastassia Stoykova
Journal:  Mol Neurobiol       Date:  2018-05-11       Impact factor: 5.590

Review 4.  Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications.

Authors:  Laurel A Grisanti; Shuchi Guo; Douglas G Tilley
Journal:  J Cardiovasc Pharmacol       Date:  2017-07       Impact factor: 3.105

Review 5.  Heart failure drug treatment.

Authors:  Patrick Rossignol; Adrian F Hernandez; Scott D Solomon; Faiez Zannad
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

6.  Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.

Authors:  Caojian Zuo; Xiaodong Li; Jun Huang; Dongrui Chen; Kaida Ji; Yan Yang; Tingyan Xu; Dingliang Zhu; Chen Yan; Pingjin Gao
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

7.  Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway.

Authors:  Liang Liu; Xian Jin; Cui-Fen Hu; Ya-Ping Zhang; Zhong'e Zhou; Rong Li; Cheng-Xing Shen
Journal:  Basic Res Cardiol       Date:  2018-01-18       Impact factor: 17.165

8.  Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20.

Authors:  Gan Liu; Luting Zhou; Hai Zhang; Rong Chen; Ye Zhang; Ling Li; Jun-Yu Lu; Hui Jiang; Dong Liu; Shasha Qi; Ying-Ming Jiang; Kai Yin; Zhifang Xie; Yuguang Shi; Yong Liu; Xuetao Cao; Yu-Xia Chen; Dajin Zou; Weiping J Zhang
Journal:  Nat Commun       Date:  2017-03-22       Impact factor: 14.919

Review 9.  The renin-angiotensin-aldosterone system and its suppression.

Authors:  Marisa K Ames; Clarke E Atkins; Bertram Pitt
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

10.  ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.

Authors:  Xin Liu; Lin Lin; Qing Li; Yajuan Ni; Chaoying Zhang; Shuguang Qin; Jin Wei
Journal:  BMC Mol Cell Biol       Date:  2019-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.